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Abstract: This study examined the safety of placing percutaneous endoscopic gastrostomy 
(PEG) tube in people with liver cirrhosis. The target population was further subdivided into people 
with ascites (case group) and people without ascites (control). We compare the morbidity and 
the mortality difference of PEG placement in cirrhotic patients with ascites vs cirrhotic patients 
without ascites. We then examined multiple factors including sex, race, chronic illness including 
hypertension, congestive heart failure, and others and their influence on the inpatient mortality of 
all cirrhotic patients who had PEG placement. A total of 38,175 inpatient PEG tube placements 
were identified. Only 583 patients out of 38,175 had a history of cirrhosis. One hundred seven 
had ascites and the rest did not. Mean age of the patients was 61.14 years. Patient demography 
included (65.2%) male and the rest were female, 359 were white (64.4%), 90 black (14.8%), 
84 Hispanic (13.7%), 23 Asians (3.3%), 7 Native Americans (0.4%), and 20 others (3.5%). 
Complications from PEG procedure in cirrhosis with ascites vs non-ascites included bleeding 
of 4 (0.8%) vs 2 (1.9%) (P=0.35), surgical site infection 2 (0.4%) vs 1 (0.9%) (P=0.51), and 
urinary tract infection 105 (22.1%) vs 34 (23.8%) (P=0.34), respectively. There was no colonic 
injury in either group. The total inpatient mortality was 75 out of the 583. Fifty-six (11.8%) 
were in the ascites group and 19 (17.8%) in the non-ascites group (P=0.097). Factors including 
ascites, postsurgical bleeding, and surgical site infection did not have influence on the inpatient 
mortality and there were no statistical differences between the two groups.
Keywords: percutaneous endoscopic gastrostomy, dysphagia, ascites, gastrointestinal
Introduction
Providing appropriate nutrition and medications can pose a significant challenge in 
the care of many patients who, for a myriad of reasons, cannot or will not eat. Enteral-
access procedures provide the short- and long-term option of providing nutrients and 
medications into the gastrointestinal tract for patients who cannot maintain adequate 
oral intake. Failure of enteral supplements, dietary counseling, and appetite stimulation 
frequently lead to a decision about the use of tube feeding.1 Percutaneous endoscopic 
gastrostomy (PEG) is one of the essential armaments to provide a means of feeding. 
As a relatively simple and safe procedure in experienced centers, it is commonly 
suggested to patients with swallowing disability seen in conditions such as stroke, 
Parkinson’s disease, and in those with head and neck cancer. Also, it can be used in 
gastric decompression in patients with severe gastroparesis, malignant bowel obstruc-
tion, or chronic intestinal obstruction.2 There are possible complications of PEG such 
as wound infection, bleeding, necrotizing fasciitis, colocutaneous fistula, and death.3
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Patients with liver cirrhosis usually end up with malnutri-
tion because of loss of appetite,4 frequent hospitalizations, 
early satiety due to ascites,5 frequent paracentesis, altered 
mental status, fat- and lipid-soluble vitamins malabsorption 
due to bile acid depletion,6 bacterial overgrowth due to poor 
small intestine motility, pancreatic insufficiency, overzeal-
ous dietary restrictions, and medications such as diuretics 
and lactulose.7–10 Because of these aforementioned issues, 
nutrition and medication administration leads to an increased 
economic burden and negative health consequences.
Use of a PEG tube improves the nutritional status of cir-
rhotic patients and helps them to survive surgeries like liver 
transplant.11 Though, one of the relative contraindication to 
PEG tube placement is ascites owing to the concerns of ascitic 
fluid leakage.12 The following article will discuss the risk of 
the complications of PEG tube such as infection, bleeding, 
and mortality in patients with liver cirrhosis.
Methods
The 2009 National Inpatient Sample (NIS) was used. The 
NIS is the largest all-payer inpatient care database containing 
around 8 million hospital stays from about 1,000 hospitals in 
the USA. These data are collected as part of the Healthcare 
Cost and Utilization Project by the Agency for Healthcare 
Research and Quality. The NIS is designed to approximate 
a 20% sample of US nonfederal hospitals, including public 
hospitals and academic medical centers assigned by the 
American Hospital Association.
Each hospital record includes a unique patient identifier, 
demographic data, admission type, primary and secondary 
diagnosis and procedures, primary and secondary insurance 
payers, length of stay including hospital charges, and hospital 
characteristics. Hospital geographic region is subcategorized 
into Northeast, Midwest, West, and South. The control/
ownership of the hospitals is classified as government non-
federal (public), private not-for-profit (voluntary), and private 
investor-owned (proprietary).
Case and outcome variable identifications
The Clinical Modification of the International Classification 
of Diseases, Ninth Revision (ICD-9) diagnostic codes were 
used to capture all admissions in the NIS dataset with the 
primary diagnosis of liver cirrhosis (5718). The following 
ICD-9 codes were also used: PEG tube placement (4311), 
ascites (789,51,78,959), postoperative bleeding (998.11), 
surgical site infection (99,859), urinary tract infection (UTI) 
(5990), and colonic injury (86,350). Other variables used in 
this study have already been identified in the NIS data, for 
instance, race, congestive heart failure, hypertension, and 
obesity.
Statistical analysis
The target population is cirrhotic patients who underwent 
PEG procedure. The target population was further subdivided 
into people with ascites and people without ascites.
The primary outcome of the study is examining the 
morbidity and the mortality difference of PEG placement in 
cirrhotic patients with ascites and cirrhotic patients without 
ascites. We then examined multiple factors including sex, 
race, chronic illness including hypertension, congestive heart 
failure, and obesity and their influence on the inpatient mor-
tality of all cirrhotic patients who underwent PEG placement.
Data were analyzed using the IBM SPSS version 24 
statistical software for Mac computer. Mean, percentages, 
and standard deviation of the mean were used to examine 
the demographic feature of the target population. Multivari-
ate logistic regression statistical test is used to compare the 
mortality and morbidity difference between these two groups. 
A CI of 95% and P value <0.05 were determined to define 
the statistical difference between the two groups.
Results
A total of 38,175 of inpatient PEG tube placements were 
identified using ICD-9 code within the NIS database. Only 
583 patients out of 38,175 had a history of cirrhosis. One 
hundred seven had ascites and the rest were without ascites. 
Mean age of the patient was 61.14 years.
Patients demography included (65.2%) male and the rest 
were female, 359 were white (64.4%), 90 black (14.8%), 84 
Hispanic (13.7%), 23 Asians (3.3%), 7 Native Americans 
(0.4%), and 20 others (3.5%) (Table 1).
The complications from PEG procedure in cirrhosis 
with ascites vs non-ascites included bleeding of 4 (0.8%) vs 
Table 1 Target population demography
Demographic Percentage
Age, years, mean 61.14
Sex, n (%)
Male 380 (65.2)
Female 203 (34.8)
Race, n (%)
White 359 (64.4)
African American 90 (14.8)
Hispanic 84 (13.7)
Asian 23 (3.3)
Native American 7 (0.4)
Other 20 (3.5)
Mean length of stay in days 15.84
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2 (1.9%) (P=0.35, odds ratio [OR]=2.24, 95% CI 04–12.34), 
surgical site infection of 2 (0.4%) vs 1 (0.9%) (P=0.51, 
OR=2.23, 95% CI 0.2–2.4), and UTI of 105 (22.1%) vs 34 
(23.8%) (P=0.34, OR 1.6, 95% CI 1.03–2.6). There was no 
colonic injury in either group. The total inpatient mortality 
was 75 out of the 583. Fifty-six (11.8%) in the ascites group 
vs 19 (17.8%) in the non-ascites (P=0.097, OR 1.5, 95% CI 
0.9–2.8) (Table 2).
Multiple factors including ascites, postsurgical bleed-
ing, surgical site infection, UTI, sex, race congestive heart 
failure, chronic lung disease, diabetes, hypertension, and 
obesity were examined to see if there was any influence on 
the inpatient mortality. None of the factors mentioned above 
were of statistically significant risk (Table 3).
Discussion
Over the last two decades, the use of enteral feeding inter-
ventions has become an increasingly popular modality for 
administering nutrition and medications in patients who 
are unable to consume by mouth for a variety of reasons.13 
Although PEG placement is technically simple to perform, it 
has a general complication rate of up to 50% and major com-
plications occur in up to 7% of cases. Commonly reported 
complications after PEG include wound infection, aspiration 
pneumonia, UTI, and bleeding.14,15 Several prior studies have 
demonstrated low albumin levels, high C-reactive protein 
levels, advanced age, low body mass index, and multiple 
comorbidities as potential risk factors for increased mortality 
and complication rates of PEG placement.16,17
Very limited data exist today regarding PEG tube place-
ment in a cirrhotic patient. Few small case series have dis-
played mortality and complication rates among this patient 
population but with mixed results. One commonly encoun-
tered issue in a cirrhotic patient is the risk of performing a 
PEG placement in the setting of ascites. To date this study 
represents the largest number (n=107) of cirrhotic patients 
with ascites undergoing PEG tube placement to better risk 
stratify which risk factors lead to poor clinical outcomes. Even 
as early as a decade ago, ascites was cited to be an absolute 
contraindication to PEG placement because of the believed 
increased risk for developing peritonitis.18 According to a case 
series study, the overall mortality of patients with cirrhosis 
who underwent PEG might reach 38%–42%.11 Nine of the 10 
patients who died in the first 30 days had ascites at the time 
of PEG tube placement. Two patients died as a direct conse-
quence of complications from the PEG procedure, whereas 
the other deaths were related to progression of liver disease 
or factors not directly related to the PEG. The authors in the 
above study did not compare cirrhotic patients with ascites vs 
cirrhotic patients without ascites, and they made an assump-
tion that ascites is an independent risk factor while their result 
was only describing the percentage of the people who died. In 
our study, the number of people who died in the cirrhosis with 
ascites group was 19 vs 56 in the cirrhosis non-ascites group. 
Although cirrhotic patients with ascites had an adjusted OR 
of 1.6 of being more likely to die during hospitalization than 
people without ascites, this was not statistically significant as 
the P value was >0.05 (P value 0.115 and 95% CI 0.89–2.86).
Our finding could be different for several potential reasons 
from previous studies that showed ascites as an independent 
risk factor. One of the reasons is that the national inpatient 
data unfortunately lack the Model for End-Stage Liver Dis-
ease (MELD) or Child–Pugh score, which has an influence 
on the mortality statistics of people with liver cirrhosis, and 
people in our target population might have a different lower 
MELD score than the target population in previous studies. 
The amount of ascites also cannot be assessed in this data, 
which could also have an effect on the procedure outcome.
Table 2 Complication from percutaneous endoscopic gastrostomy tube placement
Complication Ascitis 107 vs non-ascitis 476 P-value Odds ratio 95% CI
Postoperative bleeding 4 (0.8%) 2 (1.9%) 0.35 2.244 0.45–12.3
Surgical site infection 2 (0.4%) 1 (0.9%) 0.51 2.23 0.2–2.4
Urinary tract infection 105 (22.1%) 34 (23.8%) 0.34 1.6 1.03–2.6
Colonic injury 0.00 0.00
Table 3 Risk factor and inpatient mortality
Condition P-value Odds ratio 95% CI
Esophageal varices 0.97 1.02 0.29–3.53
Ascites 0.115 1.5 0.89–2.86
Sex 0.496 0.83 0.48–1.41
Race 0.002 0.145 0.9–1.67
Congestive heart failure 0.097 1.67 0.911–3.08
Lung disease 0.353 1.3 0.748–2.25
Diabetes mellitus 0.138 1.5 0.87–2.67
Hypertension 0.085 0.6 0.38–1.06
Obese 0.411 1.4 0.61–3.25
Urinary tract infection 0.769 1.0 0.60–1.95
Postoperative bleeding 0.289 2.5 0.45–14.2
Surgical site infection 0.941 0.9 0.09–5.80
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Our study had certain limitations in that the NIS is a 
retrospective database using administrative ICD-9 codes, 
thus questioning the accuracy of coding procedures. It also 
does not have information about the specific technique used 
in a procedure. NIS is unable to display readmission rates; 
therefore, the mortality rate could be underestimated in the 
given patient population. NIS data are unable to identify the 
main cause of death as the database includes only general 
inpatient mortality. Our data does not include the outpatient 
encounters, which could introduce selection bias. Finally, 
there could also be a clerical error involved as the database 
is taken from charts completed by humans, with human 
error, as well as completion of charts from many different 
institutions across the USA. While several limitations may 
exist, we believe that these are counterbalanced by the 
large sample size and absence of reporting bias as evident 
in some publications from specialized centers or those with 
a financial interest.
Conclusion
Our study showed by using the largest sample of patients so 
far, that PEG placement in cirrhosis patients with ascites has 
a higher mortality rate than non-cirrhotics but they were not 
statistically different.
Disclosure
The authors report no conflicts of interest in this work.
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